RECENT DEVELOPMENTS IN THE TREATMENT OF LUNG-CANCER

被引：13

作者：

LIN, AY

IHDE, DC

机构：

[1] NCI,OSN,MED ONCOL BRANCH,BLDG 31,ROOM 11A48,BETHESDA,MD 20892

[2] UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20814

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1992年 / 267卷 / 12期

关键词：

D O I：

10.1001/jama.267.12.1661

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1661 / 1664

页数：4

共 33 条

[1] CANCER STATISTICS, 1991
BORING, CC
SQUIRES, TS
TONG, T
[J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1991, 41 (01) : 19 - 36
[2] TENIPOSIDE (VM-26), AN OVERLOOKED HIGHLY-ACTIVE AGENT IN SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL IN UNTREATED PATIENTS
BORK, E
HANSEN, M
DOMBERNOWSKY, P
HANSEN, SW
PEDERSEN, AG
HANSEN, HH
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) : 524 - 527
[3] PULMONARY TOXICITY WITH COMBINED MODALITY THERAPY FOR LIMITED STAGE SMALL-CELL LUNG-CANCER
BROOKS, BJ
SEIFTER, EJ
WALSH, TE
LICHTER, AS
BUNN, PA
ZABELL, A
JOHNSTONEARLY, A
EDISON, M
MAKUCH, RW
COHEN, MH
GLATSTEIN, E
IHDE, DC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) : 200 - 209
[4] CHEMOTHERAPY ALONE OR CHEMOTHERAPY WITH CHEST RADIATION-THERAPY IN LIMITED STAGE SMALL-CELL LUNG-CANCER - A PROSPECTIVE, RANDOMIZED TRIAL
BUNN, PA
LICHTER, AS
MAKUCH, RW
COHEN, MH
VEACH, SR
MATTHEWS, MJ
ANDERSON, AJ
EDISON, M
GLATSTEIN, E
MINNA, JD
IHDE, DC
[J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (05) : 655 - 662
[5] CORTESE DA, 1983, J THORAC CARDIOV SUR, V86, P373
[6] A RANDOMIZED PHASE-I/II TRIAL OF HYPERFRACTIONATED RADIATION-THERAPY WITH TOTAL DOSES OF 60.0 GY TO 79.2 GY - POSSIBLE SURVIVAL BENEFIT WITH GREATER-THAN-OR-EQUAL-TO 69.6 GY IN FAVORABLE PATIENTS WITH RADIATION-THERAPY ONCOLOGY GROUP STAGE-III NON-SMALL-CELL LUNG-CARCINOMA - REPORT OF RADIATION-THERAPY ONCOLOGY GROUP 83-11
COX, JD
AZARNIA, N
BYHARDT, RW
SHIN, KH
EMAMI, B
PAJAK, TF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) : 1543 - 1555
[7] CULLEN JW, 1989, CANCER PRINCIPLES PR, P181
[8] DEVESA SS, 1990, J NATL CANCER I, V6, P162
[9] A RANDOMIZED TRIAL OF INDUCTION CHEMOTHERAPY PLUS HIGH-DOSE RADIATION VERSUS RADIATION ALONE IN STAGE-III NON-SMALL-CELL LUNG-CANCER
DILLMAN, RO
SEAGREN, SL
PROPERT, KJ
GUERRA, J
EATON, WL
PERRY, MC
CAREY, RW
FREI, EF
GREEN, MR
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) : 940 - 945
[10] CISPLATIN PLUS ETOPOSIDE CONSOLIDATION FOLLOWING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE IN LIMITED SMALL-CELL LUNG-CANCER
EINHORN, LH
CRAWFORD, J
BIRCH, R
OMURA, G
JOHNSON, DH
GRECO, FA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) : 451 - 456

← 1 2 3 4 →